Jiangsu Zhongdan Pharmaceutical

Jiangsu Zhongdan Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a core subsidiary of the Jiangsu Zhongdan Group. The company specializes in the production of high-quality Active Pharmaceutical Ingredients (APIs) and finished drug products, with a strong emphasis on small molecule chemistry. Their therapeutic portfolio is heavily weighted toward cardiovascular medicine, featuring major generic products such as Atorvastatin, Rosuvastatin, and Clopidogrel. Operating out of GMP-compliant facilities in Taixing, the company serves both the Chinese domestic market and international clients through its CDMO and export divisions. Jiangsu Zhongdan Pharmaceutical is recognized for its integrated approach to chemical synthesis and pharmaceutical formulation.